INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

71,123 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Nov 2, 2026Nov 4, 2026
Page 121 of 1779
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

0
Silbermann BenjaminDirector, 10% Owner
PINSPINTEREST, INC.
Derivative conversion · 10b5-1 plan
C—
46.9K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,620 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
GN
Ghamsari NimaDirector, HEAD OF BLEND
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
22.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
KT
Krasnow ToddDirector
SYMSymbotic Inc.
Other acquisition or disposition · 10b5-1 plan
J—
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
KT
Krasnow ToddDirector
SYMSymbotic Inc.
Other acquisition or disposition · 10b5-1 plan
J—
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M—
1,402 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M$22K
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M$36K
1,199 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
SC
Syrvalin Kristine CEVP General Counsel
MTUSMetallus Inc.
Option exercise · 10b5-1 plan
M—
3 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M—
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$38K
131 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Option exercise · 10b5-1 plan
M$28K
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
Silbermann BenjaminDirector, 10% Owner
PINSPINTEREST, INC.
Derivative conversion · 10b5-1 plan
C—
46.9K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Option exercise · 10b5-1 plan
M$5,626
325 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
Silbermann BenjaminDirector, 10% Owner
PINSPINTEREST, INC.
Derivative conversion · 10b5-1 plan
C—
46.9K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Option exercise · 10b5-1 plan
M$32K
14.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M$26K
856 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
DJ
Daunt JohnEVP, Chief Commercial Officer
LQDTLIQUIDITY SERVICES INC
Option exercise · 10b5-1 plan
M—
325 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
SC
Syrvalin Kristine CEVP General Counsel
MTUSMetallus Inc.
Option exercise · 10b5-1 plan
M$52.38
3 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
WJ
Wassil JimEVP, Chief Scientific Ofc, COO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M$12K
2,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
23.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
CE
Cowan ElviaSVP, Finance & CAO
PCVXVaxcyte, Inc.
Option exercise · 10b5-1 plan
M$78K
3,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
BC
Bealmear Richard CraigChief Financial Officer
OKLOOklo Inc.
Option exercise · 10b5-1 plan
M—
5,369 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Option exercise · 10b5-1 plan
M—
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
BJ
Bertolini JeffreyChief Operating Officer
CARLCARLSMED, INC.
Option exercise · 10b5-1 plan
M$4,419
747 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Derivative conversion · 10b5-1 plan
C—
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
BJ
Bertolini JeffreyChief Operating Officer
CARLCARLSMED, INC.
Option exercise · 10b5-1 plan
M—
747 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
12.8K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
CA
Costello Beth AnnEVP and CFO
HIGHARTFORD INSURANCE GROUP, INC.
Option exercise · 10b5-1 plan
M—
31.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Grant or award · 10b5-1 plan
A—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
2,620 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
SR
Santana RafaelDirector, President and CEO
WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
Open-market sale · 10b5-1 plan
SELL$46K
158 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

0
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Derivative conversion · 10b5-1 plan
C—
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
AO
Atay OguzhanDirector, Chairman and CEO
BLLNBillionToOne, Inc.
Option exercise · 10b5-1 plan
M$47K
16.7K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$442K
34.7K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

0
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise · 10b5-1 plan
M—
8,799 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

0
WY
Wassenaar YvonneDirector
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
721 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence